These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10434820)

  • 1. Omitting antagonism of neuromuscular block: effect on postoperative nausea and vomiting and risk of residual paralysis. A systematic review.
    Tramèr MR; Fuchs-Buder T
    Br J Anaesth; 1999 Mar; 82(3):379-86. PubMed ID: 10434820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of reversal agents in day care procedures (with special reference to postoperative nausea and vomiting).
    Fuchs-Buder T; Mencke T
    Eur J Anaesthesiol Suppl; 2001; 23():53-9. PubMed ID: 11766248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does neostigmine administration produce a clinically important increase in postoperative nausea and vomiting?
    Cheng CR; Sessler DI; Apfel CC
    Anesth Analg; 2005 Nov; 101(5):1349-1355. PubMed ID: 16243993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neostigmine-based reversal of intermediate acting neuromuscular blocking agents to prevent postoperative residual paralysis: A systematic review.
    Tajaate N; Schreiber JU; Fuchs-Buder T; Jelting Y; Kranke P
    Eur J Anaesthesiol; 2018 Mar; 35(3):184-192. PubMed ID: 29189420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neostigmine with glycopyrrolate does not increase the incidence or severity of postoperative nausea and vomiting in outpatients undergoing gynaecological laparoscopy.
    Nelskylä K; Yli-Hankala A; Soikkeli A; Korttila K
    Br J Anaesth; 1998 Nov; 81(5):757-60. PubMed ID: 10193290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
    Bartunek A; Gilly H; Huemer G; Yildiz S; Schramm W; Lackner FX; Foldes FF
    Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of neuromuscular blockade with neostigmine has no effect on the incidence or severity of postoperative nausea and vomiting.
    Hovorka J; Korttila K; Nelskylä K; Soikkeli A; Sarvela J; Paatero H; Halonen P; Yli-Hankala A
    Anesth Analg; 1997 Dec; 85(6):1359-61. PubMed ID: 9390608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications.
    McLean DJ; Diaz-Gil D; Farhan HN; Ladha KS; Kurth T; Eikermann M
    Anesthesiology; 2015 Jun; 122(6):1201-13. PubMed ID: 25919486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of neostigmine or edrophonium on force of contraction when administered at a train-of-four ratio of 0.9 in anesthetized dogs.
    Romano M; Martin-Flores M; Sakai DM; Tseng CT; Campoy L; Gleed RD
    Vet Anaesth Analg; 2017 Nov; 44(6):1313-1320. PubMed ID: 29066245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ; Mirakhur RK; Kumar N
    Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neostigmine and edrophonium antagonism of moderate neuromuscular block induced by pancuronium or tubocurarine.
    Shorten GD; Ali HH; Goudsouzian NG
    Br J Anaesth; 1993 Feb; 70(2):160-2. PubMed ID: 8435259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of atracurium-induced neuromuscular blockade by neostigmine or edrophonium.
    Astley BA; Hughes R; Payne JP
    Br J Anaesth; 1986 Nov; 58(11):1290-5. PubMed ID: 3778793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of mivacurium-induced neuromuscular blockade with a cholinesterase inhibitor: A systematic review.
    Brinch JHW; Söderström CM; Gätke MR; Madsen MV
    Acta Anaesthesiol Scand; 2019 May; 63(5):564-575. PubMed ID: 30548256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of sugammadex and conventional reversal on postoperative nausea and vomiting: a randomized, blinded trial.
    Koyuncu O; Turhanoglu S; Ozbakis Akkurt C; Karcıoglu M; Ozkan M; Ozer C; Sessler DI; Turan A
    J Clin Anesth; 2015 Feb; 27(1):51-6. PubMed ID: 25544263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases.
    Beemer GH; Bjorksten AR; Dawson PJ; Dawson RJ; Heenan PJ; Robertson BA
    Br J Anaesth; 1991 Apr; 66(4):469-75. PubMed ID: 2025474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.